Doç.Dr.Baran Akagündüz

Consultant Medical Oncologıst

[Doç.Dr.Baran Akagündüz @drbakagun]

@NisanyanHimself Ah Sevan hocam niye sözlükle uğraştın yazılımla uğraşaydın Bill Gates senin çalışanın olurdu..

[Doç.Dr.Baran Akagündüz @drbakagun]

@NisanyanHimself Hadi inşallah

[Doç.Dr.Baran Akagündüz @drbakagun]

@fehimtastekin Fehim abi Rusya Ukrayna savaşı nükleere gidiyor. Birazda orayı anlat🙂

[JCO Oncology Practice @JCOOP_ASCO]

Associations Between Nutritional Status, Sleep Quality, and Clinical Factors in Patients With Metastatic Prostate Cancer. Co-authored by @drbakagun and @didemdogan7.

Read the full article. https://t.co/SjrvekcjUZ
#ProstateCancer #pcsm #QoL

[Doç.Dr.Baran Akagündüz @drbakagun]

@OncBrothers @LUNGevity @DRCamidge Community of course!

[Doç.Dr.Baran Akagündüz @drbakagun]

#YeniProfilResmi

[Doç.Dr.Baran Akagündüz @drbakagun]

@aydinsezer @grok witkoff ne dedi

[Yakup Ergün @dr_yakupergun]

Check out our latest review on blood-based biomarkers for detecting frailty in older cancer patients

@drbakagun
https://t.co/q9mhPrtSq7

[Yüksel Ürün @DrYukselUrun]

🧬🩸Exciting update! LB-RECIST introduces a new era for evaluating tumor response using liquid biopsy (ctDNA), addressing limits of imaging in solid tumors. A step toward precision oncology!

#LiquidBiopsy #Oncology #PrecisionMedicine #ESMO @OncoAlert @jlb_islb @ChristianRolfo @VivekSubbiah
@curijoey @isliquidbiopsy @Annals_Oncology @myESMO

https://t.co/53dHAQ4DW5

[Journal of Oncological Sciences @OfOncological]

📢Our latest release, Volume 10 Issue 3, is out now!

Thanks to all the authors for their valuable scientific contributions

https://t.co/eALzqMgRHV

[Yüksel Ürün @DrYukselUrun]

🔬 Age & Tissue-agnostic Genomic Drivers! 🧬 Understanding the role of NTRK, BRAF, and RET mutations across all ages and tumor types. Precision medicine is evolving! #CancerResearch #Oncology @OncoAlert @VivekSubbiah @Dr_R_Kurzrock

[rusen cakir @cakir_rusen]

Vedası da kendisine yakışır bir şekilde olmuş. Güle güle Genco Erkal...

[Doç.Dr.Baran Akagündüz @drbakagun]

#YeniProfilResmi

[Türker KILIÇ @turkerkilic]

GÜNEŞ SARISI - BEYİN SARISI

Soldaki NASAnın yayınladığı en detaylı GÜNEŞ fotoğrafıymış, sağdaki ise araştırmacı Danielle Beckman tarafından yayınlanan BEYİN ağlarının fotoğrafı..

Yaşamın bağlantısallık ağı içinde soldaki sarının sıcaklığı ile sağdaki sarının sıcaklığı öylesine bütünlük içinde ki..

İkisi de ‘enformasyon’😊

[Doç.Dr.Baran Akagündüz @drbakagun]

@G_LipositsMD @JesperRyg @StineBrWinther @SkuladottirH @SyddanskUni @onko_ouh @YoungSIOG @SIOGorg @DcccAge @JGeriOnc Congrats

[Yakup Ergün @dr_yakupergun]

"Mazeret Atamalarının Akademik Yükselme Üzerine Etkileri"

#Akademikakıl
@AcademikAhlak

https://t.co/kQVl4M8lcK

[Yüksel Ürün @DrYukselUrun]

ctDNA test may be key!
🩸New study shows ctDNA can predict who benefits most from a specific treatment (panitumumab) for metastatic colon cancer.
🩸ctDNA analysis seems to be more important than tumor location (left vs. right sided) for guiding treatment decisions.
🧬gene alterations associated with resistance to EGFR inhibition, including KRAS, NRAS, PTEN and extracellular domain EGFR mutations, HER2and MET amplifications, and ALK, RET and NTRK1 fusions.
@NatureMedicine @OncoAlert @isliquidbiopsy @MCristofanill
https://t.co/iJyzN6l3ky

[NEJM @NEJM]

Original Articles:

Blood-Based Test for Colorectal Cancer Screening https://t.co/n4wanKhie2

Multitarget Stool DNA Test for Colorectal Cancer https://t.co/ahwLunxgwt

Science Behind the Study: Cell-free DNA for Colorectal Cancer Screening https://t.co/rDTjLi8gDg

[Clinical Cancer Research @CCR_AACR]

The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial. https://t.co/tImo69Z9SU

[Grant R. Williams, MD, MSPH, FASCO @GrantWilliamsMD]

@ChenyuLinMD @WilliamDale_MD @DrJuneJD @SIOGorg @ASCO @EnriqueSoto8 Yes, https://t.co/wOp8RBwjDO